AIMT Quote, Trading Chart, Aimmune Therapeutics Inc.

$34.49 Last:

-0.29% Change Percent:

$34.56 Open:

$34.49 Previous Close:

$34.56 High:

$34.48 Low:

969,191 Volume:

10/12/2020 04:44:59 am Last Trade Date Time:

Quotes are delayed by 15 to 20 minutes.

Stock Date	Open Price	Close Price	High	Low	Volume
2020-10-12	34.56	34.49	34.56	34.48	969,191
2020-10-09	34.43	34.59	34.59	34.43	4,533,606
2020-10-08	34.44	34.43	34.45	34.43	762,610
2020-10-07	34.45	34.43	34.45	34.42	1,138,369
2020-10-06	34.43	34.42	34.45	34.42	1,008,073
2020-10-05	34.3	34.44	34.44	34.3	1,606,538
2020-10-02	34.43	34.35	34.43	34.33	1,635,499
2020-10-01	34.4	34.44	34.45	34.37	986,853
2020-09-30	34.33	34.45	34.47	34.33	1,788,045
2020-09-29	34.33	34.35	34.41	34.32	801,037
2020-09-25	34.29	34.33	34.35	34.28	1,048,229
2020-09-24	34.28	34.3	34.31	34.28	1,136,658
2020-09-23	34.3	34.28	34.32	34.27	2,183,405
2020-09-22	34.31	34.31	34.32	34.28	1,110,715
2020-09-21	34.35	34.32	34.38	34.28	1,497,475
2020-09-18	34.29	34.3	34.48	34.25	4,286,294
2020-09-17	34.29	34.29	34.31	34.28	1,225,213
2020-09-16	34.34	34.305	34.34	34.27	1,279,679
2020-09-15	34.27	34.31	34.32	34.25	2,598,238
2020-09-14	34.22	34.31	34.32	34.21	1,946,946

Stock Information

Aimmune Therapeutics Inc. Company Name:

AIMT Stock Symbol:

NASDAQ Market:

Get AIMT Alerts

News, Short Squeeze, Breakout and More Instantly...

AIMT - Aimmune Presents New Clinical Data From Pooled Safety Analysis in Patients Treated With PALFORZIA® for up to ~3.5 Years

— Majority of Patients Experienced Low Rates of Adverse Events, Which Declined in Frequency and Severity with Continued Treatment — — Systemic Allergic Reactions and Epinephrine Use Were Low and Decreased Over Time — Aimmune Therapeutics, ...
AIMT - European Commission Approves Aimmune's PALFORZIA® as First-Ever Treatment for Peanut Allergy in the EU

-- Peanut Allergy is One of the Most Common Food Allergies in Europe -- -- Up to 1.6% of European Children Live with Potentially Life-Threatening Peanut Allergy -- Aimmune Therapeutics, Inc., a Nestlé Health Science Company, today announced that the European Com...
AIMT - Nestlé commences tender offer for Aimmune Therapeutics, Inc.

VEVEY, Switzerland , Sept. 14, 2020 /PRNewswire/ -- Société des Produits Nestlé S.A. ("Nestlé") announced that its wholly-owned subsidiary, SPN Merger Sub, Inc. ("Purchaser"), is commencing today a cash tender offer to purchase all of the outstanding shares of common s...